Edition:
United Kingdom

SanBio Co Ltd (4592.T)

4592.T on Tokyo Stock Exchange

2,763JPY
6:00am GMT
Change (% chg)

¥33 (+1.21%)
Prev Close
¥2,730
Open
¥2,768
Day's High
¥2,883
Day's Low
¥2,746
Volume
5,269,500
Avg. Vol
2,890,193
52-wk High
¥12,730
52-wk Low
¥2,401

Chart for

About

SanBio Company Limited is a Japan-based company primarily engaged in the research and development of regenerative cells drugs. The Company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular... (more)

Overall

Beta: --
Market Cap(Mil.): ¥83,119.16
Shares Outstanding(Mil.): 45.42
Dividend: --
Yield (%): --

Financials

  4592.T Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -65.57 -- --
ROI: -57.07 8.92 14.45
ROE: -76.57 10.08 15.96

SanBio's crash causes margin calls, drags down Japan's start-up market

TOKYO A crash by a Tokyo biopharmaceutical firm's shares on Wednesday ended a month-long rally in Japan's start-up market that was fueled by retail investors feeling small-cap stocks could rise despite global economic risks.

30 Jan 2019

SanBio's crash causes margin calls, drags down Japan's start-up market

* Mothers market, +18 pct in Jan through Tuesday, tumbles 8.1 pct

30 Jan 2019

Earnings vs. Estimates